Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007
Open Access
- 3 October 2013
- journal article
- research article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 18 (40) , 20601-16
Abstract
United Kingdom (UK) guidelines recommend at least 18 months treatment for patients with multidrug-resistant tuberculosis (MDR-TB). Prior to 2008, data on treatment outcome were only available at 12 months and therefore the proportion completing treatment was unknown. This retrospective-prospective cohort study reports on treatment outcomes for MDR-TB patients notified between 2004 and 2007 and examines factors associated with successful outcomes. 70.6% (144/204) completed treatment in 24 months or more, 6.9% (14) stopped treatment, 6.9% (14) died, 7.8% (16) were lost to follow up, 0.5% (1) relapsed and 4.4% (9) were transferred overseas. Following adjustment for age, being non-UK born, non-compliance and having co-morbidities, treatment with a fluoroquinolone (OR 3.09; 95% CI 1.21-7.88; p<0.05) or bacteriostatic drug (OR 4.23; 95% CI 1.60-11.18; p<0.05) were independently associated with successful treatment outcome. Treatment completion for MDR-TB cases remains below the World Health Organization (WHO) target. Our findings support current WHO guidelines for MDR-TB treatment. The UK should consider adopting individualised regimens based on WHO recommended drugs, taking into account drug sensitivities. Improving treatment completion rates will be key to tackling further drug resistance and transmission from untreated infectious cases.Keywords
This publication has 27 references indexed in Scilit:
- Survival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort studyBMJ Open, 2011
- Factors associated with mortality in patients with tuberculosisBMC Infectious Diseases, 2010
- Factors associated with deaths among pulmonary tuberculosis patients: a case–control study with secondary dataJournal of Epidemiology and Community Health, 2008
- Multidrug- and Extensively Drug-Resistant Tuberculosis, GermanyEmerging Infectious Diseases, 2008
- Monitoring tuberculosis treatment outcome: analysis of national surveillance data from a clinical perspectiveThorax, 2008
- An intervention programme for the management of multidrug-resistant tuberculosis in FranceInternational Journal of Antimicrobial Agents, 2007
- Modern laboratory diagnosis of tuberculosisThe Lancet Infectious Diseases, 2003
- Survival of Patients with Pulmonary Tuberculosis: Clinical and Molecular Epidemiologic FactorsClinical Infectious Diseases, 2002
- Resource implications of patients with multidrug resistant tuberculosisThorax, 2000
- The Impact of Comorbidity on Mortality Following In-hospital Diagnosis of TuberculosisChest, 1998